AdventHealth – Patient Worthy

source: pixabay.com

Novel Immunotherapy Treatment for AML and MDS Developed by AdventHealth

Post author:Jessica Lynn
Post published:June 4, 2020
Post category:Acute Myeloid Leukemia Myelodysplastic syndromes

Orlando-based healthcare company AdventHealth developed a novel immunotherapy treatment designed to treat patients with AML and MDS whose conditions failed to respond to other treatments. In addition, the organization is…

CLICK HERE TO SHARE YOUR STORY!

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More